Detalles de la búsqueda
1.
Neutralization Escape by the SARS-CoV-2 Omicron Variants BA.2.12.1 and BA.4/BA.5
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22275151
2.
A rapidly adaptable biomaterial vaccine for SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-192203
3.
mRNA Vaccines Induce Rapid Antibody Responses in Mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-466863
4.
Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22268634
5.
Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270533
6.
A Novel CRISPR-Engineered, Stem Cell-Derived Cellular Vaccine
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-474336
7.
Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-448461
8.
Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21259918
9.
T cell and antibody functional correlates of severe COVID-19
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20235150
10.
SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428921
11.
Alum:CpG adjuvant enables SARS-CoV-2 RBD-induced protection in aged mice and synergistic activation of human elder type 1 immunity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-444848
12.
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21265113
13.
Epidemiological and immunological features of obesity and SARS-CoV-2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20229724
14.
Low-Dose Ad26.COV2.S Protection Against SARS-CoV-2 Challenge in Rhesus Macaques
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-428380
15.
Vaccine Protection Against the SARS-CoV-2 Omicron Variant in Macaques
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-479285
16.
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery Against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-460191
17.
An adjuvanted SARS-CoV-2 RBD nanoparticle elicits neutralizing antibodies and fully protective immunity in aged mice
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-459664
18.
Optimization of Non-Coding Regions Improves Protective Efficacy of an mRNA SARS-CoV-2 Vaccine in Nonhuman Primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-456316
19.
A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-452251
20.
Dynamics and significance of the antibody response to SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20155374